Zydus receives final approval from the USFDA for Acetazolamide Tablets USP, 125 mg and 250 mg

Zydus receives final approval from the USFDA for Acetazolamide Tablets USP, 125 mg and 250 mg

Acetazolamide is used to treat glaucoma, a condition in which increased pressure in the eye can lead to gradual loss of vision.

FPJ Web DeskUpdated: Thursday, April 06, 2023, 04:44 PM IST
article-image
Zydus receives final approval from the USFDA for Acetazolamide Tablets USP, 125 mg and 250 mg | Image: Zydus (Representative)

Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Acetazolamide Tablets USP, 125 mg and 250 mg (USRLD: Diamox Tablets, 125 mg and 250 mg).

Acetazolamide is used to treat glaucoma, a condition in which increased pressure in the eye can lead to gradual loss of vision. Acetazolamide decreases the pressure in the eye. Acetazolamide is also used to reduce the severity and duration of symptoms (upset stomach, headache, shortness of breath, dizziness, drowsiness, and fatigue) of altitude (mountain) sickness. The drug is used with other medicines to reduce edema (excess fluid retention) and to help control seizures in certain types of epilepsy. The product will be manufactured at the group’s formulation manufacturing facility in Baddi, Himachal Pradesh (India).

Acetazolamide Tablets USP, 125 mg and 250 mg had annual sales of USD 16 mn in the United States (IQVIA MAT Dec. 2022).

The group now has 358 approvals and has so far filed over 440* ANDAs since the commencement of the filing process in FY 2003-04.

RECENT STORIES

Thousands To Lose Jobs: Microsoft Hits Workforce With Another Massive Layoff In Just Months

Thousands To Lose Jobs: Microsoft Hits Workforce With Another Massive Layoff In Just Months

Starlink Free To Roll Out India Services Once In-SPACe Approvals Are Done: Union Minister...

Starlink Free To Roll Out India Services Once In-SPACe Approvals Are Done: Union Minister...

Gold Extends Gain For 2nd Straight Day, Climbs ₹500 Per 10 Grams; Silver Trades Flat

Gold Extends Gain For 2nd Straight Day, Climbs ₹500 Per 10 Grams; Silver Trades Flat

Apple Faces Trouble In India, Chinese Workers Leaving Foxconn Factory

Apple Faces Trouble In India, Chinese Workers Leaving Foxconn Factory

Tata Steel Confident To Complete Green Steel Transition In Europe As Planned: Chairman N...

Tata Steel Confident To Complete Green Steel Transition In Europe As Planned: Chairman N...